Funding & Resources
The Gene Therapy Institute (GTI) supports innovative projects and interdisciplinary collaborations to foster outstanding basic, clinical, and translational research on gene therapy topics. The Institute provides seed funding for gene therapy research collaborations, cost-sharing grants to acquire shared equipment and services, and other relevant resources that enhance the research capabilities of the GTI community.
Pilot Awards
Seed grants for teams of researchers to collect pilot data in pursuit of extramural project and clinical trial funding.
Resource Awards
Cost-sharing grants to acquire shared equipment, services, and resources that enhance the research capabilities of the GTI community.
Vector Production
Dedicated funding toward research-grade vector productions for GTI core faculty member labs through Andelyn Biosciences.
2024 Recipients
Non-viral reprogramming-based gene therapy for limb ischemia in a pig model
- Principal Investigators: Daniel Gallego-Perez, PhD (Department of Biomedical Engineering) and Mitchel Stacy, PhD (Department of Surgery)
Harnessing olfactory pathways in Alzheimer's disease using central nervous system trophic factor gene therapy
- Principal Investigators: Lluis Samaranch, PhD (Department of Neurological Surgery) and Ahmad Karkhah Farkhani, PhD (Department of Neurological Surgery)
2025 Recipients
A tale of two capsids: Comparison of a novel AAV capsid with current gold standard AAV9 capside in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis
- Principal Investigators: Megan Baird, PhD (Department of Neurology) and Steve Kolb, MD, PhD (Departmens of Neurology and Biological Chemistry & Pharmacology)
Design and structural analysis of modified AAV capsids to target pericytes
- Principal Investigators: Amy Gleichman, PhD (Departments of Biological Chemistry & Pharmacology and Neurological Surgery) and Chuck Bell, PhD (Department of Biochemistry)
Prime Assembly for Therapeutic Gene Insertion in Duchenne Muscular Dystrophy
- Principal Investigators: Bin Liu, PhD (Department of Biological Chemistry & Pharmacology) and Stefan Nicolau, MD (Nationwide Children's Hospital)
Gene Therapy for Fuchs Endothelial Corneal Dystrphy
- Principal Investigators: Liujiang Song, PhD (Departments of Biological Chemistry & Pharmacology and Ophthalmology & Visual Sciences) and Mengying Hu, PhD (Departments of Pharmaceutics & Pharmacology)
Ohio State Funding Opportunities
-
President's Research Excellence Program
The President's Research Excellence program provides seed support for cross- and interdisciplinary research that has the potential to attract external funding.
-
Research Travel Program
A travel program opportunity for Ohio State's research and creative expression community to create new opportunities for large, multidisciplinary team projects.
-
Central Cost Share
When a sponsor requires quantifiable resources from the central univeristy, this process provides a standard experience across colleges.
-
Internal Limited Competition Funding Portal
This portal includes limited federal funding opportunities identified by the Research Development Office for management and limited foundation funding opportunities managed by the Office of Foundation Relations.
-
Office of Knowledge Enterprise
On demand information and tools to support proposal development and skills for research leadership.
-
Foundation Relations
The Foundation Relations team creates connections and supports the building of mutually beneficial partnerships between private foundations and Ohio State's research community.